MedPath

Physical Activity and Bariatric Surgery

Not Applicable
Completed
Conditions
Bariatric Surgery Candidate
Interventions
Other: Physical activity
Registration Number
NCT05050968
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Brief Summary

Bariatric surgery indeed leads to significant weight loss, reduces mortality risk, obesity-associated comorbidities (Wolfe et al., 2016) and improves functional physical abilities (Herring et al., 2016). Because these benefits are related to decreased energy intake, the investigators aim to optimize them by combining them with supervised adapted physical activity practice.

So, the aim of this clinical trial is to measure the effects of a physical training program on physical fitness, body composition and quality of life of obese women who have undergone bariatric surgery.

Detailed Description

Upon hospitalization for their bariatric surgery (bypass or sleeve), subjects will sign their informed consent and be included in the study. Six weeks' post-surgery, the subjects will be randomized in one of the 2 groups (Control group CG or Adapted Physical Activity group APAG). Patients in both groups will have 3 postoperative visits one at 6 weeks (V1), one at 18 weeks (V2) and one at 30 weeks (V3). During these visits, they will undergo the same assessments (body composition, physical condition, quality of life). Patients in the CG will receive standard hospital management. Patients in APAG will follow the same management and will also follow a 3-month physical activity program 3 times a week between V1 and V2. Then, between V2 and V3, no APA program will be offered to both groups.

The subjects will evaluate during each visit V1, V2 and V3:

* body composition,

* physical condition,

* quality of life

* daily physical activity

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
37
Inclusion Criteria
  • women between 18 and 55 years old
  • undergoing bariatric surgery (a "bypass gastric" or a "sleeve")
  • not practicing a supervised physical activity
  • having read and signed an informed consent prior to the start of the trial
  • being affiliated to a social security system
Read More
Exclusion Criteria
  • Women with a contraindication to physical activity
  • any medical contraindication to the practice of stress tests.
  • unable to go to the hospital regularly
  • having a significant functional limitation that does not allow her to perform the 6-minute walk test
  • with an intellectual disability and/or psychiatric illness
  • does not speak and/or understand French
  • pregnant woman
  • under guardianship or curatorship
  • participating in another clinical research
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adapted Physical Activity GroupPhysical activityPatients will follow a 3-month physical activity program 3 times a week between V1 and V2. Then, between V2 and V3, no APA program will be offered to both groups.
Primary Outcome Measures
NameTimeMethod
Maximum oxygen consumption (VO2 max)Week 30

The VO2 max is measured during an effort test with progressively increasing and maximum load which consists in making the subject pedal against an increasing load

Secondary Outcome Measures
NameTimeMethod
Heart rateWeek 30

The heart rate (beats/min) will be evaluated during the 6 minutes walk test

Perception of the effortWeek 36

This will be evaluated with a Borg scale (the minimum score is 0 = no exertion and the maximal 10 = maximal exertion) at the end of the 6-minutes walk test.

Impact of obesity on the physical, psycho-social, dietary well-being and dieting experience assessed using the Quality of Life, Obesity and Diet Scale (QOLDS)Week 30

QoL will be assessed using a simplified version of the French obesity-specific QoL questionnaire developed by Ziegler et al. Each participant will be asked to evaluate 14 statements about their life on a 4-point Likert scale (with 1 representing total disagreement and 4 representing total agreement). The 14 statements (eg, "Because of my weight, I have trouble to dress or undress") will equally be divided between physical aspects of life and psychosocial aspects of life. A French obesity-specific QoL questionnaire will be used to calculate the participants' physical dimension of QoL scores and psychoso-cial dimension of QoL scores by summing the points for each relevant item (range: 7-28 points). The total score will also be calculated (range: 14-56 points). The higher the scores, the better the QoL.

Walking distanceWeek 30

The walking distance (meters) will be evaluated during the 6 minutes walk test

grip strengthweek 30

The grip strength will be evaluated with a dynamometer that can be squeezed very hard for 3 seconds. The measurement will be evaluated three times with 30 seconds of recovery and the maximum value will be retained.

Metabolic measurementsweek 30

During the constant workload exercise, blood samples will be taken and metabolic measurements will be made:

- Blood Lactate (mmol/L)

Hormonal measurementsweek 30

During the constant workload exercise, blood samples will be taken and hormonal measurements will be made:

* Testosterone (ng/ml)

* Cortisol (ng/ml)

Maximum voluntary force of the quadricepsweek 30

The maximum voluntary isometric strength of the knee extensors (strength of quadriceps in kilograms) will be measured with a MicroFET2 handheld dynamometer.

Each participant's lower extremity could be placed in a position a knee flexion of 90 degrees. They will be asked to apply maximal force against the dynamometer held by the physical therapist. Before the test, the participants will be given a standard instruction of "push as hard as you can." Encouragement to apply maximal effort will also be given during the test. Each participant will be instructed to exert maximal strength for 3-5 seconds until the examiner instructed the patient to relax.

Body compositionweek 30

Body composition will be assessed by a body composition analyser in the morning on an empty stomach

Trial Locations

Locations (1)

CHR Orléans

🇫🇷

Orleans 2, France

© Copyright 2025. All Rights Reserved by MedPath